WDR62 Mutation Detection Assay for Cortical Malformation Diagnosis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for effectively detecting recessive mutations in genes involved in cortical development, particularly in carrier subjects and affected individuals with neurological disorders such as intellectual disability and cerebral cortical malformations.
Innovation Solution
A method for determining the presence of mutations in the WD repeat domain 62 (WDR62) gene by comparing test samples with control sequences, using techniques like PCR, Northern analysis, and direct sequence analysis to identify specific mutations including deletions, nonsense, and missense mutations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional mapping approaches are used for gene discovery in cortical development disorders, then diagnostic classification can be established, but locus heterogeneity and small kindred sizes hinder effective gene discovery
Solution Approach 1:
The patent applies whole-exome sequencing technology, representing a fundamental parameter change from traditional mapping approaches. This technological shift enables comprehensive detection of genetic variants across the entire exome, overcoming the limitations of locus heterogeneity and small family sizes by providing high-throughput, high-resolution genetic analysis that can identify causative mutations even in complex scenarios
2Measurement precision
If whole-exome sequencing is used to improve gene discovery, then detection capability is enhanced, but assay complexity and computational requirements increase
Solution Approach 1:
The patent extracts and focuses on specific mutations of interest from the comprehensive whole-exome sequencing data. By identifying and isolating particular variant types (such as recessive mutations in cortical development genes), the method manages the complexity of whole-exome sequencing while maintaining high detection precision for clinically relevant findings
3Measurement precision
If comprehensive genetic testing is performed to detect all mutation types, then diagnostic accuracy improves, but cost and time requirements increase
Solution Approach 1:
The patent employs preliminary bioinformatic filtering and prioritization strategies to identify likely pathogenic variants before comprehensive validation. By pre-screening for specific mutation patterns and focusing on genes associated with cortical development disorders, the method reduces the time required for comprehensive genetic testing while maintaining high diagnostic accuracy
Data Source
AI summary
The present invention relates to compositions and methods for detecting mutations in WD repeat domain 62 (WDR62).